Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

10.40
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
9.30
Today|||52-Week Range
17.55
-23.25%
Year-to-Date
Lilly Inks Deal to Include Dexcom Products in Diabetes System
Nov 22 / Zacks.com - Paid Partner Content
Top 10 Stocks Under $20
Nov 20 / Zacks.com - Paid Partner Content
Catalyst Initiates Phase II Study for Pipeline Drug Firdapse
Nov 22 / Zacks.com - Paid Partner Content
Roche Reports Positive Data From Tecentriq Combination Study
Nov 20 / Zacks.com - Paid Partner Content
Valeant Closes Senior Note Offering, Reprices Term Loan
Nov 22 / Zacks.com - Paid Partner Content
Galapagos' CF Candidate Shows Potential in Phase II Study
Nov 20 / Zacks.com - Paid Partner Content
Novartis (NVS) Receives EC Nod for Tasigna Label Expansion
Nov 22 / Zacks.com - Paid Partner Content
Collegium (COLL) in Focus: Stock Moves 6.9% Higher
Nov 16 / Zacks.com - Paid Partner Content
Alnylam's RNAi Candidate Gains Breakthrough Therapy Status
Nov 21 / Zacks.com - Paid Partner Content
Incyte (INCY) Initiates Essential Thrombocythemia Trial
Nov 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close10.40
Today’s open10.35
Day’s range10.35 - 10.50
Volume207,662
Average volume (3 months)500,440
Market cap$482.7M
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-42.47%
Earnings growth (this year)-27.17%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+50.19%
P/E ratioNM
Price/Sales2.58
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
PETQPetIQ Inc0.000.00%
INOInovio Pharmaceutica...0.000.00%
GTHXG1 Therapeutics Inc0.000.00%
ABEOAbeona Therapeutics ...0.000.00%
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)$0.35
Annual revenue (last year)$230.1M
Annual profit (last year)$18.5M
Net profit margin8.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Peter P. Pfreundschuh
Corporate headquarters
Rockville, Maryland

Forecasts